Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam Ivermectin, α7 Nicotinic Acetylcholine Receptor Modulator, Solid, 250 mg

Catalog No. 502706420
Encompass_Preferred
Change view
Click to view available options
Quantity:
250 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-6420 250 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-6420 Supplier Abcam Supplier No. AB141813250MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Positive allosteric modulator of α7 nicotinic acetylcholine receptors and antihelmintic compound.

  • Molecular Weight: 875.1 Da
  • Purity: >96%
  • Physical Form: Solid
  • Activity: Positive allosteric modulator of α7 neuronal nicotinic acetylcholine receptors and P2X4 receptors; antihelmintic; modulates glutamate- and GABA-activated chloride channels; potentiates glycine-gated currents at low concentrations (30 nM)
  • Storage Buffer: 100% Ivermectin

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Form Solid
Content And Storage Store at -20°C.
Buffer 100% Ivermectin
Shipping Condition Ambient
Target Molecule Alpha7 Nicotinic Acetylcholine Receptor, P2X4 Receptor, Glutamate-activated Chloride Channels, GABA-activated Chloride Channels, Glycine Receptor
Formulation 100% Ivermectin
Quantity 250 mg
For Use With (Application) Neuroscience-alpha7 nicotinic acetylcholine receptors, Neuroscience-P2X4 receptors, Antihelmintic research
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.